Jason P. Sinnwell

1.7k total citations
58 papers, 867 citations indexed

About

Jason P. Sinnwell is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Jason P. Sinnwell has authored 58 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 19 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Jason P. Sinnwell's work include Genetic Associations and Epidemiology (18 papers), Cancer Genomics and Diagnostics (11 papers) and Genetic Mapping and Diversity in Plants and Animals (8 papers). Jason P. Sinnwell is often cited by papers focused on Genetic Associations and Epidemiology (18 papers), Cancer Genomics and Diagnostics (11 papers) and Genetic Mapping and Diversity in Plants and Animals (8 papers). Jason P. Sinnwell collaborates with scholars based in United States, Canada and China. Jason P. Sinnwell's co-authors include Daniel J. Schaid, Terry M. Therneau, Shannon K. McDonnell, Stephen N. Thibodeau, William R. Sukov, Rhett P. Ketterling, John C. Cheville, Joanna M. Biernacka, Krishna R. Kalari and Matthew P. Goetz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jason P. Sinnwell

54 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason P. Sinnwell United States 17 324 273 136 136 133 58 867
Periklis Makrythanasis Switzerland 18 278 0.9× 402 1.5× 80 0.6× 83 0.6× 111 0.8× 58 798
James T. Lu United States 14 417 1.3× 407 1.5× 127 0.9× 106 0.8× 42 0.3× 26 843
Kai Yu United States 16 238 0.7× 671 2.5× 183 1.3× 228 1.7× 131 1.0× 42 1.2k
Jacob A. Reiss United States 19 514 1.6× 273 1.0× 87 0.6× 45 0.3× 115 0.9× 43 1.0k
Richard H. Scott United Kingdom 21 676 2.1× 760 2.8× 53 0.4× 155 1.1× 159 1.2× 42 1.5k
Nisha Padmanabhan United Kingdom 14 119 0.4× 457 1.7× 148 1.1× 188 1.4× 79 0.6× 19 832
Nathan D. Montgomery United States 17 201 0.6× 613 2.2× 273 2.0× 124 0.9× 70 0.5× 53 1.1k
Arti Tandon United States 15 1.1k 3.3× 359 1.3× 113 0.8× 163 1.2× 220 1.7× 21 1.6k
Zhaoming Wang United States 19 207 0.6× 497 1.8× 241 1.8× 213 1.6× 186 1.4× 74 1.3k
Alicja Waliszewska United States 7 622 1.9× 241 0.9× 62 0.5× 97 0.7× 209 1.6× 9 1.0k

Countries citing papers authored by Jason P. Sinnwell

Since Specialization
Citations

This map shows the geographic impact of Jason P. Sinnwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason P. Sinnwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason P. Sinnwell more than expected).

Fields of papers citing papers by Jason P. Sinnwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason P. Sinnwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason P. Sinnwell. The network helps show where Jason P. Sinnwell may publish in the future.

Co-authorship network of co-authors of Jason P. Sinnwell

This figure shows the co-authorship network connecting the top 25 collaborators of Jason P. Sinnwell. A scholar is included among the top collaborators of Jason P. Sinnwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason P. Sinnwell. Jason P. Sinnwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koch, J., et al.. (2025). Genetics of morphological hip abnormalities and their implications for osteoarthritis: a scoping review. Journal of Hip Preservation Surgery. 12(3). 202–216. 1 indexed citations
2.
Leon‐Ferre, Roberto A., Jodi M. Carter, David M. Zahrieh, et al.. (2024). Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer. npj Breast Cancer. 10(1). 25–25. 1 indexed citations
3.
Comba, Işın Y., Ruben A. Mars, Lu Yang, et al.. (2024). 309 THE BASELINE GUT MICROBIOME OFFERS INSIGHTS INTO PREDICTING AND UNDERSTANDING THE HETEROGENEOUS NATURE OF LONG COVID. Gastroenterology. 166(5). S–66. 1 indexed citations
4.
Stan, Daniela, Daniel J. Schaid, Erin E. Carlson, et al.. (2023). Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up. Cancer Prevention Research. 17(2). 77–84. 1 indexed citations
5.
Tang, Xiaojia, Kevin J. Thompson, Krishna R. Kalari, et al.. (2023). Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors. Breast Cancer Research. 25(1). 57–57. 2 indexed citations
6.
Sicotte, Hugues, Krishna R. Kalari, Sisi Qin, et al.. (2022). Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment. Molecular Cancer Research. 20(12). 1739–1750. 9 indexed citations
7.
Yu, Jia, Yongxian Zhuang, Xiaoyang Fan, et al.. (2022). Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer. Cancers. 14(17). 4220–4220. 11 indexed citations
8.
Thompson, Kevin J., Roberto A. Leon‐Ferre, Jason P. Sinnwell, et al.. (2022). Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response. NAR Cancer. 4(2). zcac018–zcac018. 26 indexed citations
9.
Qin, Sisi, Huanyao Gao, Wootae Kim, et al.. (2022). Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration‐Resistant Prostate Cancer. Clinical Pharmacology & Therapeutics. 111(6). 1296–1306. 8 indexed citations
10.
Carter, Jodi M., Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, et al.. (2021). Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer. Clinical Cancer Research. 27(20). 5628–5637. 35 indexed citations
11.
Boughey, Judy C., Vera J. Suman, Jia Yu, et al.. (2021). Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY). Clinical Cancer Research. 27(17). 4696–4699. 13 indexed citations
12.
Polley, Mei‐Yin C., Maura N. Dickler, Jason P. Sinnwell, et al.. (2021). A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy. Breast Cancer Research and Treatment. 189(1). 15–23. 4 indexed citations
13.
Matey, Eric T., Lance J. Oyen, Carolyn R. Rohrer Vitek, et al.. (2021). Nine-gene pharmacogenomics profile service: The Mayo Clinic experience. The Pharmacogenomics Journal. 22(1). 69–74. 23 indexed citations
14.
Schaid, Daniel J., Celine M. Vachon, Andrew Cooke, et al.. (2020). Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake. Cancer Prevention Research. 14(2). 175–184. 10 indexed citations
15.
16.
Kalari, Krishna R., Jason P. Sinnwell, Kevin J. Thompson, et al.. (2018). PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient. JCO Clinical Cancer Informatics. 2(2). 1–11. 11 indexed citations
17.
Hart, Steven N., Marissa S. Ellingson, Peter T. Vedell, et al.. (2016). Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer. BMJ Open. 6(4). e010332–e010332. 28 indexed citations
18.
19.
Sukov, William R., et al.. (2010). Development of Five Dual-Color, Double-Fusion Fluorescence in Situ Hybridization Assays for the Detection of Common MLL Translocation Partners. Journal of Molecular Diagnostics. 12(4). 441–452. 9 indexed citations
20.
Sukov, William R., Rhett P. Ketterling, Donna J. Lager, et al.. (2009). CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. Human Pathology. 40(9). 1296–1303. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Periklis Makrythanasis Breakdown of academic impact, for papers by James T. Lu Breakdown of academic impact, for papers by Kai Yu Breakdown of academic impact, for papers by Jacob A. Reiss Breakdown of academic impact, for papers by Richard H. Scott Breakdown of academic impact, for papers by Nisha Padmanabhan Breakdown of academic impact, for papers by Nathan D. Montgomery Breakdown of academic impact, for papers by Arti Tandon Breakdown of academic impact, for papers by Zhaoming Wang Breakdown of academic impact, for papers by Alicja Waliszewska
Rankless by CCL
2026